share_log

Pfizer | 4: Statement of changes in beneficial ownership of securities-Officer BOURLA ALBERT

Pfizer | 4: Statement of changes in beneficial ownership of securities-Officer BOURLA ALBERT

輝瑞 | 4：持股變動聲明-高管 BOURLA ALBERT
美股SEC公告 ·  09/04 06:07

牛牛AI助理已提取核心訊息

Pfizer Inc. (PFE) has reported a significant transaction by Chairman & CEO Albert Bourla. The transaction, which took place on 08/30/2024, involved Bourla dealing with non-derivative securities of the company. However, the specific details regarding the number of shares, nature of the shares, transaction price, and the total value of the shares were not disclosed in the announcement. The action reflects a notable change in Bourla's holdings in Pfizer, but without the complete data, the impact on his total share ownership remains unclear.
Pfizer Inc. (PFE) has reported a significant transaction by Chairman & CEO Albert Bourla. The transaction, which took place on 08/30/2024, involved Bourla dealing with non-derivative securities of the company. However, the specific details regarding the number of shares, nature of the shares, transaction price, and the total value of the shares were not disclosed in the announcement. The action reflects a notable change in Bourla's holdings in Pfizer, but without the complete data, the impact on his total share ownership remains unclear.
輝瑞公司（PFE）的董事長兼首席執行官阿爾伯特·布爾拉進行了一項重大交易。該交易發生在2024年08月30日，涉及到布爾拉與公司的非衍生證券的交易。然而，關於股票數量、股票性質、交易價格以及股票的總價值的具體細節並未在公告中披露。這一行動反映了布爾拉在輝瑞公司的持股情況發生了顯著變化，但由於缺乏完整的數據，對他總持股量的影響目前仍不清楚。
輝瑞公司（PFE）的董事長兼首席執行官阿爾伯特·布爾拉進行了一項重大交易。該交易發生在2024年08月30日，涉及到布爾拉與公司的非衍生證券的交易。然而，關於股票數量、股票性質、交易價格以及股票的總價值的具體細節並未在公告中披露。這一行動反映了布爾拉在輝瑞公司的持股情況發生了顯著變化，但由於缺乏完整的數據，對他總持股量的影響目前仍不清楚。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生，只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    熱議
    美股
    股票代碼最新價升跌幅

    暫無數據

    資訊熱榜
    更新時間